SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-02-000020
Filing Date
2002-11-14
Accepted
2002-11-14 10:50:59
Documents
5
Period of Report
2002-09-30

Document Format Files

Seq Description Document Type Size
1 LIGAND 09-30-02 10Q ligand090210q.htm 10-Q 280769
3 EX 4.7 - 4TH AMEND TO PREF SHARED RIGHTS AGRMNT ex4-7.txt EX-4 18747
4 EX 10.247 PHARMA AMENDMENT ex10-247.txt EX-10 5824
5 EX 99.1 - CEO CERTIFICATION ex99-1.txt EX-99 1451
6 EX 99.2 - CFO CERTIFICATION ex99-2.txt EX-99 1429
  Complete submission text file 0000886163-02-000020.txt   310239
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20720 | Film No.: 02822485
SIC: 2834 Pharmaceutical Preparations